Atlas FDA

MEDSTONE STS-TC/U LITHOTRIPTER

FDA premarket approval P970042/S003 · decided 2003-02-14

Approval details

PMA number
P970042
Supplement
S003
Supplement type
Normal 180 Day Track
Supplement reason
Change Design/Components/Specifications/Material
Trade name
MEDSTONE STS-TC/U LITHOTRIPTER
Generic name
Lithotripter, shockwave (for treating gallbladder stones)
Applicant
Medstone Intl., Inc.
Date received
2002-07-03
Decision date
2003-02-14
Days to decision
226 days
Decision code
APPR
Product code
NCV
Advisory committee
Gastroenterology, Urology
Expedited review
No
Location
Aliso Viejo, CA
Statement
APPROVAL FOR THE STS-TC/U LITHOTRIPTER (TRANSPORTABLE VERSION OF THE STS LITHOTRIPTER WITH ULTRASOUND). THE DEVICE, AS MODIFIED, WILL BE MARKETED UNDER THE TRADE NAME MEDSTONE STS-TC/U LITHOTRIPTER AND IS INDICATED FOR 1) THE FRAGMENTATION OF SYMPTOMATIC UPPER URINARY TRACT STONES, I.E., RENAL CALYCEAL STONES, RENAL PELVIC STONES, AND UPPER URETERAL STONES, AND 2) WHEN USED IN CONJUNCTION WITH CERTAIN URSODIOLS, IS INDICATED FOR THE TREATMENT OF SYMPTOMATIC, SOLITARY, RADIOLUCENT, NON-CALCIFIED

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
MEDSTONE, UROPRO 2000, TOMOGRAPHIC OPTION (K013620)Medstone Intl., Inc.2002-01-22
STS-T LITHOTRIPTER, MODEL STS-T (K010900)Medstone Intl., Inc.2001-04-05
STS(TM) FLUOROSCOPIC IMAGING MODULE (K905278)Medstone Intl., Inc.1991-02-04